PNT News and Press, POINT Biopharma Global Inc.

NORTHAMPTON, MA / ACCESSWIRE / June 25, 2024 / Pentair Greg Claffey, Group President, Pentair Pool (right) presents Pentair Pool Step Into Swim sponsorship check to Rowdy Gaines, Vice President Partnerships and Development, PHTA, and Olympic Gold Medalist. As published on the Pentair Blog . ...

LONDON, UK / ACCESSWIRE / April 18, 2024 / Pentair plc (NYSE:PNR), a leader in helping the world sustainably move, improve and enjoy water, life's most essential resource, today released its 2023 Corporate Responsibility Report, reporting on the Company's efforts and progress toward Making Bett...

2024-02-25 12:00:00 ET More on AstraZeneca, Bristol-Myers, etc. Eli Lilly: Will It Be The First Ever Trillion-Dollar Drug Company? Eli Lilly: Yes, It Is Too Late To Join The Party Eli Lilly: Very Strong Fundamentals, But Market Is Euphoric Phase 3 data for As...

2024-01-06 09:26:57 ET More on retail stocks XRT ETF: Not The Best Bet Wall Street Breakfast Catalyst Watch: Walmart, Target's Mixed Signals XRT: Retail Is Still Not Where I Want To Be Will retail reset as inflation and supply chain trends finally normalize? ...

2024-01-05 14:30:17 ET More on the markets SPY And QQQ: Fundamentals Remain Strong, Buying The Dip Verily Volatility: SPY Puts Are Cheap And The Market Is Selling Off The Market Looks Poised To Make New Highs In 2024 ETFs attract $597B in 2023 marking the fou...

2023-12-27 11:03:53 ET More on Fusion Pharmaceuticals RBC says Bristol Myers/RayzeBio deal validates Fusion 's approach Fusion Pharma shares jump following expanded actinium supply deal with BWXT Seeking Alpha’s Quant Rating on Fusion Pharmaceuticals H...

2023-12-27 09:10:12 ET More on Eli Lilly Eli Lilly: Consider Cutting Before The Southbound Train Leaves (Rating Downgrade) Eli Lilly: Long Path To A Trillion Bubble Warning: Unrealistic Growth Priced In And Multiple Risk Factors For Eli Lilly Eli Lilly purcha...

Lilly Completes Acquisition of POINT Biopharma PR Newswire INDIANAPOLIS , Dec. 27, 2023 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) today announced the successful completion of its acquisition of POINT Biopharma Global Inc. (NASDAQ: PNT), a radiopharmaceuti...

2023-12-26 12:16:48 ET More on Fusion Pharmaceuticals Fusion Pharma shares jump following expanded actinium supply deal with BWXT Seeking Alpha’s Quant Rating on Fusion Pharmaceuticals Historical earnings data for Fusion Pharmaceuticals Financial infor...

2023-12-26 07:43:47 ET More on POINT Biopharma Global Why POINT Biopharma Global Is At Least A Hold On Disappointing Readout POINT Biopharma Global: Why The Market Believes That A Second Bidder May Emerge Eli Lilly POINTs Toward Radiopharmaceutical Ambitions ...